Neurosoft Bioelectronics Receives Nearly $3M in Funding for Clinical Study on Epilepsy

eNewsChannels NEWS: -- Neurosoft Bioelectronics, an early-stage company developing tools for unmet needs in epilepsy and tinnitus, was awarded nearly $3 million USD, from the SERI-Funded European Innovation Council Accelerator Grant and a share of the $165,000 USD through the European Research Council Proof-of-Concept Grant. :: News from eNewsChannels

Related Keywords

New York ,United States ,Switzerland ,Swiss ,Neurosoft Bioelectronic ,Nicolas Vachicouras ,Neurosoft Bioelectronics ,Swiss Federal Institute Of Technology ,European Innovation Council Accelerator Grant ,Bioelectronic Medicine Forum ,Neurosoft Bioelectronics Ltd ,European Research Council Grant ,Fongit Innovation Fund ,Development For Tinnitus Application ,Fund Clinical Study ,Neurosoft Bioelectronics Flexible ,Will Fund Clinical Study ,Regulatory Approval ,Advance Development ,European Research Council Proof Of Concept ,Fongit Innovation ,Swiss Federal Institute ,Brain Computer Interface ,